Mended Little Hearts 2016 Roar 'N Run Virtual Charity Race
Jan 26, 2016 13:11 pm UTC| Business
DALLAS, Jan. 26, 2016 -- Next month during CHD Awareness Week (Feb. 7-14), runners from around the world will be sending out a ROAR for Congenital Heart Disease awareness by participating in the Mended Little Hearts 2016...
EQ Labs Announces New Last Shot Can Design and Product Rollout
Jan 26, 2016 13:00 pm UTC| Business
Las Vegas, NV, Jan. 26, 2016 -- EQ Labs, Inc. (“EQ.” or “the Company”) (OTC.BB: EQLB), is pleased to announce the new design and marketing of our lead product “Last Shot”. “EQ LABS, is proud to announce its new...
CDTi to Present at the Source Capital Group’s 2016 Disruptive Growth & Healthcare Conference
Jan 26, 2016 13:00 pm UTC| Business
OXNARD, Calif., Jan. 26, 2016 -- Clean Diesel Technologies, Inc. (Nasdaq:CDTI) (“CDTi” or “the Company”), a leader in advanced emission control technology, announced it will present at the Source Capital Group 2016...
Jan 26, 2016 13:00 pm UTC| Business
#1 Ranking market maker by dollar value traded OTC#1 Ranking market maker in ~2,500 securitiesAdded 45% of all new foreign securities and ADRs to the OTC Market Alternative Trading System Averaged 1.13 executions per order...
Cutera, Inc. to Announce Results for the Fourth Quarter Ended December 31, 2015
Jan 26, 2016 13:00 pm UTC| Business
BRISBANE, Calif., Jan. 26, 2016 -- Cutera, Inc. (Nasdaq:CUTR), a leading provider of laser and other energy-based aesthetic systems for practitioners worldwide, will announce results for the fourth quarter ended...
Griffin Capital Acquires $1.7 Billion of Single-Tenant Assets in 2015
Jan 26, 2016 13:00 pm UTC| Business
EL SEGUNDO, Calif., Jan. 26, 2016 -- Griffin Capital Corporation (“Griffin Capital”), the sponsor of several REIT platforms, proudly announces the acquisition of 37 properties totaling nearly $1.7 billion in purchase...
Cempra to Ring NASDAQ Closing Bell to Mark 10th Anniversary
Jan 26, 2016 13:00 pm UTC| Business
CHAPEL HILL, N.C., Jan. 26, 2016 -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the treatment of bacterial infectious diseases,...